Epac2: A Molecular Target for Sulfonylurea-Induced Insulin Release

Simon A. Hinke^*

Department of Pharmacology, University of Washington, Box 357750, Seattle, WA 98195, USA.

Abstract: Sulfonylurea drugs are used in type 2 diabetes mellitus therapy to induce release of endogenous insulin from pancreatic β cells. They act on sulfonylurea receptors, which are the regulatory subunits of adenosine triphosphate (ATP)–sensitive potassium ion (K_ATP) channels and cause channel closure to trigger exocytosis. Epac2 was identified as an intracellular target for sulfonylurea drugs, providing a potential nonelectrogenic signaling component to the mechanism of action for these agents. Commonly used sulfonylureas such as tolbutamide and glibenclamide induced Epac2 activation with distinct kinetic profiles. Epac2^–/– mice failed to respond to sulfonylureas, suggesting that both sulfonylurea receptors and Epac2 are necessary for the action of these drugs. These data require that the cellular and physiological effects of drugs that alter the open state of the K_ATP channel be reassessed.

* Corresponding author. E-mail, shinke{at}u.washington.edu

The editors suggest the following Related Resources on Science sites:

In Science Signaling

RESEARCH ARTICLES
Cell Biology
Spatial Control of Epac2 Activity by cAMP and Ca²⁺-Mediated Activation of Ras in Pancreatic β Cells

Olof Idevall-Hagren, Ida Jakobsson, Yunjian Xu, and Anders Tengholm (30 April 2013)
Sci. Signal. 6 (273), ra29. [DOI: 10.1126/scisignal.2003932]
 |  Editor's Summary »  |  Abstract »  |  Full Text »  |  PDF »  |  Supplementary Materials »

EDITORS' CHOICE
Cell Biology
Inhibited at the Nucleus

Wei Wong (21 June 2011)
Sci. Signal. 4 (178), ec173. [DOI: 10.1126/scisignal.4178ec173]
 |  Abstract »

EDITORS' CHOICE
Cell Biology
Expanding Sulfonylurea Mechanisms

L. Bryan Ray (4 August 2009)
Sci. Signal. 2 (82), ec263. [DOI: 10.1126/scisignal.282ec263]
 |  Abstract »

EDITORS' CHOICE
Spatial Regulation
Get Busy and Get Going

L. Bryan Ray (12 May 2009)
Sci. Signal. 2 (70), ec161. [DOI: 10.1126/scisignal.270ec161]
 |  Abstract »

PERSPECTIVES
STKE Perspectives
Diabetes Outfoxed by GLP-1?

George G. Holz and Oleg G. Chepurny (25 January 2005)
Sci. STKE 2005 (268), pe2. [DOI: 10.1126/stke.2682005pe2]
 |  Abstract »  |  Full Text »  |  PDF »

In Science Magazine

REPORTS
The cAMP Sensor Epac2 Is a Direct Target of Antidiabetic Sulfonylurea Drugs

Chang-Liang Zhang, Megumi Katoh, Tadao Shibasaki, Kohtaro Minami, Yasuhiro Sunaga, Harumi Takahashi, Norihide Yokoi, Masahiro Iwasaki, Takashi Miki, and Susumu Seino (31 July 2009)
Science 325 (5940), 607. [DOI: 10.1126/science.1172256]
 |  Abstract »  |  Full Text »  |  PDF »  |  Supporting Online Material »